COPD

June 17, 2016June 17, 2016

Spray Polyurethane Foam Alliance Urges Asthma Prevention Through Proper Building Insulation

Asthma, Chronic Bronchitis, COPD, Emphysema, News

The trade association Spray Polyurethane Foam Alliance (SPFA) is urging consumers, businesses, and builders in the U.S. to help prevent asthma and asthma-related attacks by using responsible building materials to lower rates of ... Read more

June 16, 2016June 16, 2016

Frail COPD Patients Benefit from Pulmonary Rehabilitation, Study Reveals

COPD, News

Researchers at King’s College London, in collaboration with several other U.K. institutions, found that pulmonary rehabilitation is helpful for frail patients with chronic obstructive pulmonary disease (COPD). Findings from the study “Physical frailty ... Read more

June 1, 2016June 3, 2016

Salford Lung Study Shows Reduction in COPD Exacerbations with Relvar Ellipta

COPD, News

GlaxoSmithKline reported positive results from the pioneering Salford Lung Study (SLS) evaluating Relvar Ellipta 100/25 mcg for the treatment of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Relvar is ... Read more

May 25, 2016May 25, 2016

COPD Patients in US Face Significant Challenges in Accessing Treatment, Researchers Say

COPD, News

Leading U.S. experts in chronic obstructive pulmonary disease (COPD) have found that patients with the condition face substantial barriers in assessing care, with hospitals failing to provide recommended standard of care, ... Read more

May 23, 2016May 23, 2016

COPD Researchers Underscore Potential of Tailored, Holistic Approach to Treatment

COPD, News

The REG 2016 Annual Summit (Respiratory Effectiveness Group) on April 15–16 in Lyon, France, attracted several speakers who emphasized the need for more research into the nature and effectiveness of treatments for ... Read more

May 23, 2016May 23, 2016

Acute COPD Improved by Inhibitor, Approved Bronchodilators

COPD, News

Verona Pharma has announced positive results from the Phase 2a trial evaluating a phosphodiesterase (PDE) 3/4 inhibitor, RPL554, in patients with chronic obstructive pulmonary disorder (COPD). COPD is a progressive ... Read more

May 20, 2016May 20, 2016

Positive Data on COPD Therapy Breo Ellipta SUMMIT Study Presented by GSK

COPD, News

GlaxoSmithKline (GSK) and Innoviva recently presented positive results from two analyses of the SUMMIT trial, which investigated the efficacy and safety of Breo Ellipta (fluticasone furoate/vilanterol, or FF/VI 100/25 mcg) in patients with chronic obstructive pulmonary disease (COPD) ... Read more

May 20, 2016May 20, 2016

U. Washington Scientists’ Sensing Tool Measures Lung Function over Calls from any Phone, Anywhere

Asthma, COPD, Cystic Fibrosis, News

Most people in the developing world who live with asthma, cystic fibrosis, or other chronic lung diseases have no way of measuring the status of their lung function outside of ... Read more

May 19, 2016May 19, 2016

Phase 3 Drug Improves Lung Function for COPD Patients with Symptoms After Tiotropium

COPD, News

A new phase 3 clinical study conducted by GSK and Innoviva, Inc. shows that Anoro Ellipta significantly improves lung function in people with COPD, compared to another drug called tiotropium.

May 16, 2016May 16, 2016

AstraZeneca to Spotlight Respiratory Medicine ATS 2016

Asthma, COPD, News

The biopharmaceutical AstraZeneca recently announced key presentations set to spotlight its large respiratory disease medicines repertoire, during the American Thoracic Society (ATS) International Conference in San Francisco through May 18. The data ... Read more